Open access
57
Views
4
CrossRef citations to date
0
Altmetric
Original Research
Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4
Jill Ohar1 Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA, [email protected]Correspondence[email protected]
, Robert Tosiello2 Sunovion Pharmaceuticals Inc., Marlborough, MA, USA
, Thomas Goodin2 Sunovion Pharmaceuticals Inc., Marlborough, MA, USA
& Shahin Sanjar2 Sunovion Pharmaceuticals Inc., Marlborough, MA, USA
Pages 27-37
|
Published online: 18 Dec 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.